Potassium Iodide (KI)

Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Potassium iodide (KI) is the standardized inorganic form of iodine, the mineral the thyroid needs to make thyroid hormone. It is used in two very different worlds. As a nutrient it supplies the roughly 150 micrograms of iodine a day adults need, and it is one of the two salts, with potassium iodate, used in iodized salt programs to prevent and correct deficiency. As a prescription-strength medicine, at doses hundreds of times higher and only under medical direction, it is used to block radioactive iodine uptake in a nuclear emergency and to prepare an overactive thyroid for surgery. Those medical uses are not benefits of taking an iodine supplement. Distinct from kelp-derived iodine (which has variable iodine content and contamination concerns).

Studied Dose Nutritional: 150 µg iodine/day RDA for adults, matching typical supplements. The 130 mg KI/day radiation dose is over 600 times that, only when public health authorities direct it.
Active Compound Potassium iodide (KI)

Benefits

Iodine Deficiency Prevention/Treatment

Iodine deficiency is the leading preventable cause of intellectual disability worldwide, and an estimated 2 billion people still have insufficient iodine intake, mostly in regions without effective salt iodization. Universal salt iodization (using KI or potassium iodate) has dramatically reduced cretinism and goiter, and has made most of the developed world iodine sufficient, so people already getting enough from iodized salt, dairy and seafood have little to gain from adding more. Potassium iodide is one of the standard forms for population-level iodine fortification. One caution comes from the same literature: Zimmermann and Boelaert report that a population adapted to mild deficiency keeps normal thyroid function but at a price, a higher rate of autonomous thyroid nodules, and that raising iodine intake in such a population causes a transient rise in hyperthyroidism.

Medical use, not a supplement benefit: nuclear emergency thyroid blocking

This is a medical use rather than something a supplement does. KI tablets are FDA-approved for thyroid protection during radioactive iodine release events such as nuclear power plant accidents. The adult emergency dose is 130 mg of KI, about 100 mg of iodine, which is more than 600 times the 150 microgram daily nutritional requirement, and it is taken only when public health authorities direct it, once a day and only for as long as the risk of exposure lasts. Protection is specific to radioactive iodine and to nothing else, and taking iodine every day does not confer it. Mechanism: saturating the thyroid with stable iodine prevents radioactive iodine-131 uptake. Distributed by federal/state emergency management programs near nuclear facilities.

Medical use, not a supplement benefit: pre-operative thyroid preparation

This is a surgical protocol rather than something a supplement does. Lugol's solution (potassium iodide plus iodine) is given under medical supervision for a short period before thyroid surgery in hyperthyroidism, because high-dose iodine reduces thyroid gland vascularity and decreases hormone release (Wolff-Chaikoff effect). Nobody should take Lugol's solution or high-dose iodine on their own to try to calm an overactive thyroid, and the same iodine load can push a susceptible thyroid the other way.

Standardized Pharmaceutical

Unlike kelp-derived iodine, whose iodine content varies widely and which has been found to carry arsenic (Amster 2007 measured arsenic above the FDA tolerance in eight of nine kelp supplements tested, and reported a case of arsenic toxicosis traced to one), potassium iodide has a precisely known iodine content and consistent dosing. Pharmaceutical-grade quality assurance. Preferred form for clinical applications.

Medical use, not a supplement benefit: sporotrichosis

This is a prescribing fact rather than something a supplement does, and an iodine supplement is not a treatment for any infection. A saturated solution of potassium iodide (SSKI), prescribed and monitored by a doctor at doses far above nutritional intake, has long been used for cutaneous sporotrichosis, a fungal infection picked up from rose thorns or sphagnum moss. It is still used in some settings, though itraconazole is now first-line.

Mechanism of action

1

Thyroid Iodine Uptake

Iodine is concentrated by the thyroid gland (sodium-iodide symporter / NIS) for thyroid hormone synthesis. T3 and T4 contain 3 and 4 iodine atoms respectively. Iodine deficiency impairs thyroid hormone production → goiter (compensatory thyroid enlargement) and hypothyroidism.

2

Wolff-Chaikoff Effect (High-Dose Iodine)

Acute high-dose iodine (>1 mg/day) transiently inhibits thyroid hormone synthesis — basis for hyperthyroidism pre-op preparation. Most patients escape this effect within 1-2 weeks (Plummer effect); chronic high-dose iodine can cause iodine-induced hyperthyroidism in susceptible individuals (Jod-Basedow phenomenon).

3

Radioactive Iodine Blocking

Stable potassium iodide saturates thyroid iodine binding sites, preventing uptake of radioactive I-131 (released in nuclear accidents). Most effective if taken within 4-6 hours of exposure; effectiveness diminishes after 12-24 hours.

4

Mucolytic and Antifungal Properties

High-dose iodine has mild antifungal activity (basis for sporotrichosis use) and historical mucolytic use (chronic bronchitis); displaced by modern pharmaceuticals. Both effects belong to prescription-scale doses and have nothing to do with nutritional iodine intake.

Clinical trials

1
Potassium Iodide for Radiation Protection: Chernobyl Experience
PubMed

Program experience rather than a controlled comparison. After Chernobyl in 1986 Poland distributed KI within days to the great majority of its children, while distribution across the most contaminated parts of Belarus and Ukraine was late and patchy. (Becker and Zanzonico 1997, Thyroid)

Pediatric populations near Chernobyl.

What was actually measured in Poland was radiation dose, not cancer. Becker and Zanzonico report that about 16 million people received a single administration of KI with only rare side effects and a probable 40 percent reduction in projected thyroid radiation dose. Poland did not see the surge in childhood thyroid cancer that followed in Belarus and Ukraine, but Poland also received far less fallout and restricted contaminated milk and local produce, so the lower cancer rate cannot be credited to KI alone. On chronology, the FDA had already concluded in 1978 that KI was safe and effective for blocking radioiodine uptake, eight years before Chernobyl; the Chernobyl data informed the later dosing guidance rather than the original approval. None of this bears on everyday iodine supplementation.

2
Universal Salt Iodization: WHO Programs (population data, not a trial)
PubMed

WHO global iodine deficiency disorder elimination programs using iodized salt (potassium iodide or potassium iodate fortification). These are public health programs measured at population level, not tests of an iodine supplement in individuals.

Iodine-deficient populations globally.

Universal salt iodization has dramatically reduced goiter prevalence and cretinism in formerly iodine-deficient regions, and it is one of the most cost-effective public health interventions there is. Potassium iodide and potassium iodate are equivalent for fortification purposes. What this does not show is that an iodine supplement helps someone who already gets enough. Where iodine supplements have been tested by randomized trial, the result has not always been positive: a placebo-controlled trial of 200 micrograms of iodine a day in 832 mildly iodine-deficient pregnant women in India and Thailand (Gowachirapant 2017) found no effect on the children's verbal IQ, performance IQ or executive function at ages 5 to 6.

Side effects and drug interactions

Common Potential side effects

GI distress at high doses.
Metallic taste.
Iodine-induced hyperthyroidism (Jod-Basedow phenomenon) — particularly in susceptible individuals (autonomous thyroid nodules, multinodular goiter).
Iodine-induced hypothyroidism — particularly in those with autoimmune thyroid disease (Hashimoto's).
Iodism — toxicity syndrome at chronic high doses; rhinitis, headache, metallic taste, salivary gland swelling, skin rash, GI symptoms.
Allergic reactions — iodine allergy is rare but documented; cross-reactivity with shellfish allergy is myth (allergens are different proteins; iodine is not the allergen).
Pregnancy — high-dose can cross placenta and cause fetal hypothyroidism, goiter.

Important Drug interactions

ACE inhibitors / potassium-sparing diuretics — KI provides potassium load; hyperkalemia risk in CKD or with potassium-sparing meds.
Lithium — additive antithyroid effects; hypothyroidism risk.
Amiodarone — high iodine content in amiodarone can cause thyroid dysfunction; KI use complicated.
Antithyroid drugs (methimazole, propylthiouracil) — additive effects.
Levothyroxine — iodine excess can affect thyroid hormone balance.

Frequently asked questions about Potassium Iodide (KI)

What is potassium iodide used for?

Potassium iodide (KI) is a source of iodine, the mineral needed to make thyroid hormones. In small amounts it supports thyroid function; in high pharmaceutical doses it is used to protect the thyroid during radiation emergencies.

How much potassium iodide should I take?

For nutritional iodine, the daily requirement is about 150 mcg of iodine for adults. Most iodine supplements and multivitamins provide about 150 to 225 mcg. Take care with high-dose iodine products sold at 12 mg or more per tablet or dropperful, which is at least 80 times the daily requirement. The very high doses sold for radiation emergencies are a separate, medically directed use, not for daily supplementation.

Can you take too much potassium iodide?

Yes. Excess iodine can disrupt the thyroid, causing either underactive or overactive function in susceptible people. Stay near the recommended nutritional amount unless a doctor directs otherwise; do not take high-dose KI without medical guidance.

What is the difference between potassium iodide and other iodine supplements?

Potassium iodide is one common chemical form used to deliver iodine; other supplements use kelp, sodium iodide, or molecular iodine. They all supply iodine, with the key being the total iodine amount rather than the specific salt.

What is Potassium Iodide?

Potassium iodide (KI) is the standardized inorganic form of iodine, the mineral the thyroid needs to make thyroid hormone. It is used in two very different worlds.

What is the recommended dosage of Potassium Iodide?

The clinically studied dose is Nutritional: 150 µg iodine/day RDA for adults, matching typical supplements. The 130 mg KI/day radiation dose is over 600 times that, only when public health authorities direct it. Always follow the product label and check with a healthcare provider for personal advice.

Is Potassium Iodide safe, and does it have side effects?

For most healthy adults, Potassium Iodide is well tolerated at studied doses. Reported effects can include: GI distress at high doses. Metallic taste. It may also interact with some medications. Potassium Iodide is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Potassium Iodide interact with any medications?

Possible interactions include: ACE inhibitors / potassium-sparing diuretics — KI provides potassium load; hyperkalemia risk in CKD or with potassium-sparing meds. Lithium — additive antithyroid effects; hypothyroidism risk. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Potassium Iodide?

NutraSmarts rates the evidence for Potassium Iodide as Moderate (3 out of 5). It is backed by 2 clinical trials and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Leung AM, Bauer AJ, Benvenga S, Brenner AV, Hennessey JV, Hurley JR, Milan SA, Schneider AB, Sundaram K, Toft DJ. American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency. Thyroid. 2017;27(7):865-877. doi: 10.1089/thy.2017.0054.PubMedUsed to support: Authoritative position statement: stable potassium iodide (KI) blocks thyroidal uptake of radioactive iodine in nuclear emergencies, with greatest benefit taken just before/shortly after exposure; covers age-based dosing, stockpiling, and that protection is specific to radioiodine only.
  2. Becker DV, Zanzonico P. Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use. Thyroid. 1997;7(2):193-7. doi: 10.1089/thy.1997.7.193.PubMedUsed to support: Reviews the Chernobyl experience: Poland distributed KI to ~16 million people with rare side effects and an estimated ~40% reduction in projected thyroid dose; argues for KI stockpiling and explains the radioiodine-blockade rationale (saturation of iodide uptake).
  3. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286-95. doi: 10.1016/S2213-8587(14)70225-6.PubMedUsed to support: Authoritative review of iodine deficiency and its correction (iodized salt/iodide): iodine is required for thyroid hormone synthesis; deficiency causes goiter, hypothyroidism and impaired neurodevelopment, while excess iodide can also induce thyroid dysfunction (Wolff-Chaikoff).
  4. Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-induced hypothyroidism. Thyroid. 2001;11(5):501-10. doi: 10.1089/105072501300176462.PubMedUsed to support: Reviews the acute Wolff-Chaikoff effect and iodine-induced hypothyroidism: large iodide loads (as in high-dose KI) acutely inhibit thyroid hormone synthesis; most healthy thyroids escape, but failure to escape (autoimmune thyroid disease, fetuses/neonates) can cause hypothyroidism — the key high-dose-iodide caution.
  5. Gowachirapant S, Jaiswal N, Melse-Boonstra A, et al. Effect of iodine supplementation in pregnant women on child neurodevelopment: a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017;5(11):853-863..PubMedUsed to support: Randomised placebo-controlled trial of 200 micrograms of oral iodine daily in 832 mildly iodine-deficient pregnant women in Bangalore, India and Bangkok, Thailand. Both co-primary outcomes at child age 5 to 6 were null: verbal IQ 89.5 versus 90.2 (difference -0.7, p=0.77), performance IQ 97.5 versus 99.1 (difference -1.6, p=0.44) and BRIEF-P executive function 90.6 versus 91.5 (difference -0.9, p=0.74). The authors conclude that daily iodine supplementation in mildly iodine-deficient pregnant women had no effect on child neurodevelopment. Cited in the salt iodization card as the counterweight to population programme data, and the main reason the evidence level cannot be 5.
  6. Amster E, Tiwary A, Schenker MB Case report: potential arsenic toxicosis secondary to herbal kelp supplement. Environ Health Perspect. 2007;115(4):606-8..PubMedUsed to support: A woman with alopecia, memory loss, rash, fatigue and vomiting had a urine arsenic of 83.6 micrograms per gram creatinine against a normal below 50, and her kelp supplement contained 8.5 ppm arsenic; symptoms and levels resolved after she stopped taking it. The authors then analysed nine kelp products bought from health food stores and found eight of the nine above the FDA tolerance level of 0.5 to 2 ppm for certain foods. Supports the previously uncited contamination half of the standardized-form benefit, where the page contrasts potassium iodide with kelp-derived iodine.